Clinical characterization of patients with PRPF31-related retinitis pigmentosa and asymptomatic carriers: a cross-sectional study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Clinical characterization of patients with PRPF31-related retinitis pigmentosa and asymptomatic carriers : a cross-sectional study. / Lisbjerg, Kristian; Bertelsen, Mette; Grønskov, Karen; Kessel, Line.

In: Ophthalmic Genetics, Vol. 44, No. 5, 2023, p. 456-464.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lisbjerg, K, Bertelsen, M, Grønskov, K & Kessel, L 2023, 'Clinical characterization of patients with PRPF31-related retinitis pigmentosa and asymptomatic carriers: a cross-sectional study', Ophthalmic Genetics, vol. 44, no. 5, pp. 456-464. https://doi.org/10.1080/13816810.2023.2219732

APA

Lisbjerg, K., Bertelsen, M., Grønskov, K., & Kessel, L. (2023). Clinical characterization of patients with PRPF31-related retinitis pigmentosa and asymptomatic carriers: a cross-sectional study. Ophthalmic Genetics, 44(5), 456-464. https://doi.org/10.1080/13816810.2023.2219732

Vancouver

Lisbjerg K, Bertelsen M, Grønskov K, Kessel L. Clinical characterization of patients with PRPF31-related retinitis pigmentosa and asymptomatic carriers: a cross-sectional study. Ophthalmic Genetics. 2023;44(5):456-464. https://doi.org/10.1080/13816810.2023.2219732

Author

Lisbjerg, Kristian ; Bertelsen, Mette ; Grønskov, Karen ; Kessel, Line. / Clinical characterization of patients with PRPF31-related retinitis pigmentosa and asymptomatic carriers : a cross-sectional study. In: Ophthalmic Genetics. 2023 ; Vol. 44, No. 5. pp. 456-464.

Bibtex

@article{83a2969306c4413d8bec1bc97fb15172,
title = "Clinical characterization of patients with PRPF31-related retinitis pigmentosa and asymptomatic carriers: a cross-sectional study",
abstract = "Background/aim: To describe the clinical phenotype of retinitis pigmentosa (RP) caused by PRPF31-variants and clinical characterization of asymptomatic PRPF31 carriers. Materials and methods: We conducted a descriptive cross-sectional deep phenotyping study. We included subjects with PRPF31 variants predicted to be disease-causing, both individuals with RP and asymptomatic carriers. Participants underwent a comprehensive clinical examination of standard visual function parameters (visual acuity, contrast sensitivity, Goldmann visual field), full-field stimulus threshold (FST), full-field electroretinogram (ff-ERG), and a structural investigation with slit lamp and multimodal imaging. We used Spearman correlation analyses to evaluate associations between quantitative outcomes. Results: We included 21 individuals with disease-causing PRPF31-variants: 16 symptomatic and 5 asymptomatic subjects. The symptomatic subjects demonstrated a typical RP phenotype with constricted visual fields, extinguished ff-ERG, and disrupted outer retinal anatomy. FST was impaired and correlated significantly with other outcome measures in RP subjects. Structure–function correlations with Spearman correlation analysis showed moderate correlation coefficients due to a few outliers in each analysis. The asymptomatic individuals had normal best-corrected visual acuity and visual fields, but showed reduced ff-ERG amplitudes, borderline FST sensitivity, and structural abnormalities on OCT and fundoscopy. Conclusions: RP11 has a typical RP phenotype but varies in terms of severity. FST measurements correlated well with other functional and structural metrics and may be a reliable outcome measure in future trials as it is sensitive to a broad range of disease severities. Asymptomatic carriers showed sub-clinical disease manifestations, and our findings underline that reported non-penetrance in PRPF31-related RP is not an all-or-none phenomenon.",
keywords = "asymptomatic carriers, FST, non-penetrance, PRPF31, Retinitis pigmentosa, RP11",
author = "Kristian Lisbjerg and Mette Bertelsen and Karen Gr{\o}nskov and Line Kessel",
note = "Publisher Copyright: {\textcopyright} 2023 Taylor & Francis Group, LLC.",
year = "2023",
doi = "10.1080/13816810.2023.2219732",
language = "English",
volume = "44",
pages = "456--464",
journal = "Ophthalmic Genetics",
issn = "1381-6810",
publisher = "Taylor & Francis",
number = "5",

}

RIS

TY - JOUR

T1 - Clinical characterization of patients with PRPF31-related retinitis pigmentosa and asymptomatic carriers

T2 - a cross-sectional study

AU - Lisbjerg, Kristian

AU - Bertelsen, Mette

AU - Grønskov, Karen

AU - Kessel, Line

N1 - Publisher Copyright: © 2023 Taylor & Francis Group, LLC.

PY - 2023

Y1 - 2023

N2 - Background/aim: To describe the clinical phenotype of retinitis pigmentosa (RP) caused by PRPF31-variants and clinical characterization of asymptomatic PRPF31 carriers. Materials and methods: We conducted a descriptive cross-sectional deep phenotyping study. We included subjects with PRPF31 variants predicted to be disease-causing, both individuals with RP and asymptomatic carriers. Participants underwent a comprehensive clinical examination of standard visual function parameters (visual acuity, contrast sensitivity, Goldmann visual field), full-field stimulus threshold (FST), full-field electroretinogram (ff-ERG), and a structural investigation with slit lamp and multimodal imaging. We used Spearman correlation analyses to evaluate associations between quantitative outcomes. Results: We included 21 individuals with disease-causing PRPF31-variants: 16 symptomatic and 5 asymptomatic subjects. The symptomatic subjects demonstrated a typical RP phenotype with constricted visual fields, extinguished ff-ERG, and disrupted outer retinal anatomy. FST was impaired and correlated significantly with other outcome measures in RP subjects. Structure–function correlations with Spearman correlation analysis showed moderate correlation coefficients due to a few outliers in each analysis. The asymptomatic individuals had normal best-corrected visual acuity and visual fields, but showed reduced ff-ERG amplitudes, borderline FST sensitivity, and structural abnormalities on OCT and fundoscopy. Conclusions: RP11 has a typical RP phenotype but varies in terms of severity. FST measurements correlated well with other functional and structural metrics and may be a reliable outcome measure in future trials as it is sensitive to a broad range of disease severities. Asymptomatic carriers showed sub-clinical disease manifestations, and our findings underline that reported non-penetrance in PRPF31-related RP is not an all-or-none phenomenon.

AB - Background/aim: To describe the clinical phenotype of retinitis pigmentosa (RP) caused by PRPF31-variants and clinical characterization of asymptomatic PRPF31 carriers. Materials and methods: We conducted a descriptive cross-sectional deep phenotyping study. We included subjects with PRPF31 variants predicted to be disease-causing, both individuals with RP and asymptomatic carriers. Participants underwent a comprehensive clinical examination of standard visual function parameters (visual acuity, contrast sensitivity, Goldmann visual field), full-field stimulus threshold (FST), full-field electroretinogram (ff-ERG), and a structural investigation with slit lamp and multimodal imaging. We used Spearman correlation analyses to evaluate associations between quantitative outcomes. Results: We included 21 individuals with disease-causing PRPF31-variants: 16 symptomatic and 5 asymptomatic subjects. The symptomatic subjects demonstrated a typical RP phenotype with constricted visual fields, extinguished ff-ERG, and disrupted outer retinal anatomy. FST was impaired and correlated significantly with other outcome measures in RP subjects. Structure–function correlations with Spearman correlation analysis showed moderate correlation coefficients due to a few outliers in each analysis. The asymptomatic individuals had normal best-corrected visual acuity and visual fields, but showed reduced ff-ERG amplitudes, borderline FST sensitivity, and structural abnormalities on OCT and fundoscopy. Conclusions: RP11 has a typical RP phenotype but varies in terms of severity. FST measurements correlated well with other functional and structural metrics and may be a reliable outcome measure in future trials as it is sensitive to a broad range of disease severities. Asymptomatic carriers showed sub-clinical disease manifestations, and our findings underline that reported non-penetrance in PRPF31-related RP is not an all-or-none phenomenon.

KW - asymptomatic carriers

KW - FST

KW - non-penetrance

KW - PRPF31

KW - Retinitis pigmentosa

KW - RP11

U2 - 10.1080/13816810.2023.2219732

DO - 10.1080/13816810.2023.2219732

M3 - Journal article

C2 - 37293790

AN - SCOPUS:85161691713

VL - 44

SP - 456

EP - 464

JO - Ophthalmic Genetics

JF - Ophthalmic Genetics

SN - 1381-6810

IS - 5

ER -

ID: 367906665